Drug therapy : the management of gout

Drug therapy : the management of gout

The risk of systemic toxic effects (marrow suppression and injury of renal, hepatic, and central nervous system cells) is much greater with intravenous therapy than with oral therapy.

Gespeichert in:
Bibliographische Detailangaben
Veröffentlicht in:The New England journal of medicine 1996-02, Vol.334 (7), p.445-451
1. Verfasser: EMMERSON, B. T
Format: Artikel
Sprache:eng
Schlagworte:
Biological and medical sciences
Drug dosages
Medical sciences
Metabolic diseases
Other metabolic disorders
Patients
Purines and pyrimidines (gout, hyperuricemia...)
Rheumatism
Online-Zugang:Volltext
Tags: Tag hinzufügen
Keine Tags, Fügen Sie den ersten Tag hinzu!
Beschreibung
Zusammenfassung:The risk of systemic toxic effects (marrow suppression and injury of renal, hepatic, and central nervous system cells) is much greater with intravenous therapy than with oral therapy.
ISSN:0028-4793
1533-4406
DOI:10.1056/NEJM199602153340707